Samlyn Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-594,661
| Closed | -$11.1M | – | 106 |
|
|
2024
Q1 | $11.1M | Sell |
594,661
-174,241
| -23% | -$3.27M | 0.19% | 83 |
|
|
2023
Q4 | $16.7M | Buy |
768,902
+29,035
| +4% | +$629K | 0.33% | 62 |
|
|
2023
Q3 | $15.2M | Buy |
+739,867
| New | +$15.2M | 0.25% | 74 |
|
|
2017
Q3 | – | Sell |
-47,300
| Closed | -$3.77M | – | 124 |
|
|
2017
Q2 | $3.77M | Sell |
47,300
-9,400
| -17% | -$749K | 0.09% | 85 |
|
|
2017
Q1 | $4.03M | Sell |
56,700
-25,300
| -31% | -$1.8M | 0.09% | 109 |
|
|
2016
Q4 | $4.19M | Buy |
+82,000
| New | +$4.19M | 0.09% | 98 |
|